Killing of Parasites by BMAP-18
Author Information
Author(s): Haines Lee R., Thomas Jamie M., Jackson Angela M., Eyford Brett A., Razavi Morteza, Watson Cristalle N., Gowen Brent, Hancock Robert E. W., Pearson Terry W.
Primary Institution: University of Victoria
Hypothesis
Can BMAP-18 effectively kill various trypanosomatid parasites while exhibiting low toxicity to mammalian cells?
Conclusion
BMAP-18 is effective at killing a range of trypanosomatid parasites with low toxicity to mammalian cells.
Supporting Evidence
- BMAP-18 showed strong growth inhibitory activity against several species and life cycle stages of African trypanosomes.
- BMAP-18 exhibited reduced cytotoxicity on a wide variety of mammalian and insect cells compared to BMAP-27.
- BMAP-18 induced apoptosis in trypanosomes without altering their plasma membranes.
- High affinity antibodies to BMAP-18 were produced and used to detect the peptide in human blood.
Takeaway
BMAP-18 is a special peptide that can kill bad germs that make people and animals sick, but it doesn't hurt healthy cells.
Methodology
The study tested the anti-parasite activity of BMAP-18 against various trypanosomatid species in vitro, comparing its effects to those of BMAP-27.
Limitations
The study was conducted in vitro, and the effects in vivo remain to be tested.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.01
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website